Organization changes of CIISB at the Institute of Biotechnology
The CIISB facilities at IBT have been undergoing the following organizational changes.
Ten Million Euro for Access to European Proteomics Facilities
The European Union has awarded 10 million euro to a consortium of eighteen European research groups in the field of mass spectrometry-based proteomics research throughout Europe.
The European Proteomics Initiative Consortium (EPIC-XS), funded as part of the Horizon 2020 Work programme, is coordinated by Albert Heck, professor of biomolecular mass spectrometry and proteomics at Utrecht University. The project has started on the first of January 2019 and will run for a period of four years. Two Core Facilities of CIISB, Structural Mass Spectrometry, BIOCEV and Proteomic Mass Spectrometry, CEITEC are among the partners providing transnational access and participating on 4 Joint Research Activities. Proteomics, the large-scale study of proteins and their role in living cells and organisms, is an important technology used to gain insight into the function of biological systems and the roles they play in health and disease. Mass spectrometry based proteomics requires state of the art technology, in-house technical know-how, sustainable and robust workflow practices, successful and correct data interpretation, and data management. TheEPIC-XS consortium consists of partners throughout Europe, which have a proven track record in facilitating national and international research within their institutions. All partners share a common goal; to facilitate the development and sustainability of proteomics exploration to all life science researchers within the European Union.
